Coronavirus pandemic leads big drugmakers to hit pause on clinical trials
Share:
(Reuters) - U.S. drugmakers Eli Lilly and Co and Bristol Myers Squibb said they are delaying the start of new clinical trials in part to free up doctors and healthcare facilities to deal with the surge in patients infected with the new coronavirus.Lilly and Bristol are the biggest drugmakers yet to announce clinical trial delays in the face of the pandemic that has killed over 16,000 people worldwide, after several small biotech companies said last week that they would be pulling back on drug..